"WHY CHOOSE US = A Company That Cares || No health insurance is needed and no cost to you! || Those who qualify may receive: Access to new treatments being research before they are made public || Focused Time and attention from research staff and Doctors || Medical exams related to the study || Education about your study / disease ________________________________________"

During the past decade, CHEAR Center LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHEAR Center LLC" #1 sponsor was "Allergan" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "NewAmsterdam Pharma" with 2 trials sponsored, "Applied Therapeutics, Inc." with 1 trials sponsored and "Bellus Health Inc" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHEAR Center LLC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHEAR Center LLC" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Diabetic Cardiomyopathies" (1 trials). Many other conditions were trialed in "CHEAR Center LLC" in a lesser frequency.

Most popular intervention types in "CHEAR Center LLC" are "Drug" (12 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Obicetrapib" (2 trials), "Relamorelin" (2 trials), "AT-001" (1 trials) and "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHEAR Center LLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "CHEAR Center LLC". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in CHEAR Center LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHEAR Center LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".